PE20090447A1 - Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores relacionados de la gamma secretasa - Google Patents

Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores relacionados de la gamma secretasa

Info

Publication number
PE20090447A1
PE20090447A1 PE2008001184A PE2008001184A PE20090447A1 PE 20090447 A1 PE20090447 A1 PE 20090447A1 PE 2008001184 A PE2008001184 A PE 2008001184A PE 2008001184 A PE2008001184 A PE 2008001184A PE 20090447 A1 PE20090447 A1 PE 20090447A1
Authority
PE
Peru
Prior art keywords
gamma secretase
secretase inhibitors
bencensulfonil
thiochromane
chromane
Prior art date
Application number
PE2008001184A
Other languages
English (en)
Inventor
Thavalakulamgara K Sasikumar
Duane A Burnett
Theodros Asberom
Wen-Lian Wu
Ruo Xu
Hongmei Li
Hubert B Josien
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20090447A1 publication Critical patent/PE20090447A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA 1, DONDE X ES -O-, -S-, -S(O2)-, ENTRE OTROS; ----ES ENLACE OPCIONAL; Y, Z SON CADA UNO N, C; Q ES ANILLO DE 5-8 MIEMBROS FUSIONADOS CON A1 Y Q1; Q1 ES ANILLO DE 5-7 MIEMBROS CON UN HETEROATOMO SLEECIONADO DE N, O, S(O) Y S(O2) FUSIONADO CON Q; L1 ES HALOGENO, ALQUILO, -CN, -CF3, -O-(ALQUILO C1-C6), ENTRE OTROS; Ar ES ARILO SUSTITUIDO O NO, HETEROARILO SUSTITUIDO O NO. UN COMPUESTO PREFERIDO ES (5aR,13aS)-11bR-[(4-CLOROFENIL)SULFONIL]-8,11-DIFLUORO-2,3,5a,6,11b,12,13,13a-OCTAHIDRO[1]BENZOPIRANO[4',3':5,6]PIRIDO[1,2-c]PIRIMIDIN-4(1H)-ONA. DICHOS COMPUESTOS SON INHIBIDORES DE GAMMA SECRETASA UTILES EN EL TRATAMIENTO DE ALZHEIMER
PE2008001184A 2007-07-17 2008-07-15 Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores relacionados de la gamma secretasa PE20090447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95016007P 2007-07-17 2007-07-17

Publications (1)

Publication Number Publication Date
PE20090447A1 true PE20090447A1 (es) 2009-04-18

Family

ID=39831616

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001184A PE20090447A1 (es) 2007-07-17 2008-07-15 Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores relacionados de la gamma secretasa

Country Status (13)

Country Link
US (1) US8618123B2 (es)
EP (1) EP2178882B1 (es)
JP (1) JP5204227B2 (es)
KR (1) KR20100044840A (es)
CN (1) CN101970445A (es)
AR (1) AR067560A1 (es)
AU (1) AU2008276492A1 (es)
CA (1) CA2693216A1 (es)
CL (1) CL2008002084A1 (es)
PE (1) PE20090447A1 (es)
TW (1) TW200904447A (es)
WO (1) WO2009011851A1 (es)
ZA (1) ZA201000191B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548913T3 (es) 2009-09-11 2015-10-21 Probiodrug Ag Derivados heterocíclicos como inhibidores de glutaminil ciclasa
US9226927B2 (en) 2011-09-09 2016-01-05 Merck Sharp & Dohme Corp. Gamma secretase inhibitors
JP6134654B2 (ja) 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
JP6553746B2 (ja) * 2015-05-07 2019-07-31 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ ＲＯＲγ調節因子としての三環式スルホン類
JP7182553B2 (ja) * 2016-11-09 2022-12-02 ブリストル－マイヤーズ スクイブ カンパニー Ｒｏｒガンマ調節剤としての三環スルホン類
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase
CN111004198B (zh) * 2019-12-24 2023-03-28 瑞安宝源化工有限公司 一种苯并吡喃衍生物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01008606A (es) 1999-02-26 2003-05-05 Merck & Co Inc Compuestos de sulfonamida novedosos y uso de los mismos.
HUP0600673A3 (en) 2001-08-03 2011-08-29 Schering Corp Tetrahydroquinolin derivatives as gamma secretase inhibitors nad pharmaceutical compositions containing them
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
EP1638951B1 (en) * 2003-05-16 2008-02-13 MERCK SHARP & DOHME LTD. Cyclohexyl sulphones as gamma-secretase inhibitors
MX2008009414A (es) * 2006-01-20 2008-10-01 Schering Corp Arilsulfonas carbociclicas y heterociclicas como inhibidores de gamma secretasa.
UY30377A1 (es) 2006-06-02 2008-01-02 Elan Pharm Inc Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
US8664411B2 (en) 2007-07-05 2014-03-04 Merck Sharp & Dohme Corp. Tetrahydropyranochromene gamma secretase inhibitors

Also Published As

Publication number Publication date
EP2178882B1 (en) 2013-04-17
US8618123B2 (en) 2013-12-31
AU2008276492A1 (en) 2009-01-22
CL2008002084A1 (es) 2009-01-23
US20110110948A1 (en) 2011-05-12
AU2008276492A2 (en) 2010-02-18
CN101970445A (zh) 2011-02-09
JP5204227B2 (ja) 2013-06-05
KR20100044840A (ko) 2010-04-30
TW200904447A (en) 2009-02-01
WO2009011851A1 (en) 2009-01-22
EP2178882A1 (en) 2010-04-28
ZA201000191B (en) 2011-06-29
JP2010533713A (ja) 2010-10-28
CA2693216A1 (en) 2009-01-22
AR067560A1 (es) 2009-10-14

Similar Documents

Publication Publication Date Title
PE20090447A1 (es) Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores relacionados de la gamma secretasa
CY1118239T1 (el) Πυραζολο[1,5-α]πυριμιδινες και -τριαζινες ως αντι-ιικοι παραγοντες
PE20121312A1 (es) Metodo para preparar compuestos macrociclicos inhibidores de serina proteasas de hepatitis c
PE20130012A1 (es) Derivados de pirazol como inhibidores de jak
PE20081612A1 (es) Analogos de las pterinas
PE20071090A1 (es) 5-pirazolpiperidinas-(sustituidas)
PE20081192A1 (es) Tratamiento del dolor
PE20130346A1 (es) Compuestos heterociclicos fusionados
PE20091085A1 (es) NUEVOS DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA E IMIDAZO[1,2-b]-PIRIDAZINA
PE20140390A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
PE20091039A1 (es) IMIDAZO PIRAZINAS FUSIONADAS ARILO Y HETEROARILO [1,5-a] COMO INHIBIDORES DE LA FOSFODIESTERASA 10
TW200740806A (en) Bridged N-cyclic sulfonamido inhibitors of gamma secretase
PE20151249A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
TN2011000244A1 (en) Organic compounds
PE20080893A1 (es) Triazoles biciclicos como moduladores de la proteina cinasa
NZ594567A (en) 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
MX2013006101A (es) Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos.
EA201170770A1 (ru) Органические соединения
PE20040832A1 (es) Derivados de indolil pirazinona
PE20030922A1 (es) Derivados de piridina y quinolina
PE20060455A1 (es) Nucleosidos de 3-beta-d-ribofuranosiltiazolo[4,5-d]pirimidina
PE20080988A1 (es) Compuestos triciclicos fusionados de sulfonamida como inhibidores de gama-secretasa
AR059937A1 (es) Compuesto de pirido (2,3-d) pirimidin -7-ona o compuesto que contiene 3,4- dihidropirimido (4,5-d) pirimidin -2 (1h) -ona y proceso para su preparacion
PE20070010A1 (es) Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d
PE20090049A1 (es) Derivados de piridopirimidina como moduladores de la actividad de pde 4

Legal Events

Date Code Title Description
FD Application declared void or lapsed